KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Intangibles (2016 - 2021)

Supernus Pharmaceuticals (SUPN) has disclosed Change in Intangibles for 9 consecutive years, with $453000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Change in Intangibles changed N/A to $453000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $594000.0, a 55.93% decrease, with the full-year FY2019 number at $1.3 million, up 66.75% from a year prior.
  • Change in Intangibles was $453000.0 for Q1 2021 at Supernus Pharmaceuticals, up from $117000.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $5.8 million in Q2 2017 to a low of $1000.0 in Q1 2019.
  • A 5-year average of $1.1 million and a median of $343000.0 in 2018 define the central range for Change in Intangibles.
  • Biggest YoY gain for Change in Intangibles was 936.92% in 2019; the steepest drop was 99.71% in 2019.
  • Supernus Pharmaceuticals' Change in Intangibles stood at $1.0 million in 2017, then tumbled by 87.3% to $130000.0 in 2018, then soared by 936.92% to $1.3 million in 2019, then tumbled by 91.32% to $117000.0 in 2020, then skyrocketed by 287.18% to $453000.0 in 2021.
  • Per Business Quant, the three most recent readings for SUPN's Change in Intangibles are $453000.0 (Q1 2021), $117000.0 (Q3 2020), and $24000.0 (Q2 2020).